Healthcare provider profile · identity verified

Brian Mccarthy, D.O.

Internal Medicine · NORFOLK, VA · NPI 1053653899

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	918	56
Amlodipine Besylate	Amlodipine Besylate	666	59
Atorvastatin Calcium	Atorvastatin Calcium	560	43
Trazodone Hcl	Trazodone Hcl	539	39
Duloxetine Hcl	Duloxetine Hcl	453	23
Furosemide	Furosemide	427	35
Tamsulosin Hcl	Tamsulosin Hcl	420	22
Omeprazole	Omeprazole	379	30
Escitalopram Oxalate	Escitalopram Oxalate	361	23
Famotidine	Famotidine	351	26
Carvedilol	Carvedilol	348	32
Metoprolol Succinate	Metoprolol Succinate	331	21
Sertraline Hcl	Sertraline Hcl	322	33
Memantine Hcl	Memantine Hcl	307	28
Eliquis	Apixaban	290	21
Metformin Hcl	Metformin Hcl	280	13
Levothyroxine Sodium	Levothyroxine Sodium	261	24
Olmesartan Medoxomil	Olmesartan Medoxomil	261	24
Olanzapine	Olanzapine	257	17
Donepezil Hcl	Donepezil Hcl	244	26
Levetiracetam	Levetiracetam	231	18
Januvia	Sitagliptin Phosphate	229	14
Buspirone Hcl	Buspirone Hcl	228	18
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	225	14
Losartan Potassium	Losartan Potassium	215	23
Mirtazapine	Mirtazapine	214	25
Potassium Chloride	Potassium Chloride	211	15
Montelukast Sodium	Montelukast Sodium	209	14
Clopidogrel	Clopidogrel Bisulfate	204	12
Citalopram Hbr	Citalopram Hydrobromide	199	15
Quetiapine Fumarate	Quetiapine Fumarate	186	28
Midodrine Hcl	Midodrine Hcl	179	13
Bumetanide	Bumetanide	167	13
Hydrochlorothiazide	Hydrochlorothiazide	161	14
Pantoprazole Sodium	Pantoprazole Sodium	157	16
Xarelto	Rivaroxaban	155	suppressed
Finasteride	Finasteride	150	suppressed
Glipizide Er	Glipizide	144	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	122	suppressed
Allopurinol	Allopurinol	119	suppressed
Hydralazine Hcl	Hydralazine Hcl	118	15
Metformin Hcl Er	Metformin Hcl	114	suppressed
Lisinopril	Lisinopril	104	12
Metformin Er Osmotic	Metformin Hcl	99	suppressed
Gabapentin	Gabapentin	96	27
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	92	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	91	11
Metoprolol Tartrate	Metoprolol Tartrate	91	17
Jardiance	Empagliflozin	90	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	81	81
Venlafaxine Hcl Er	Venlafaxine Hcl	81	suppressed
Spironolactone	Spironolactone	74	suppressed
Baclofen	Baclofen	69	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	65	suppressed
Dapagliflozin	Dapagliflozin Propanediol	65	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	65	suppressed
Divalproex Sodium	Divalproex Sodium	64	14
Oxybutynin Chloride	Oxybutynin Chloride	64	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	63	suppressed
Topiramate	Topiramate	58	suppressed
Acarbose	Acarbose	57	suppressed
Ibandronate Sodium	Ibandronate Sodium	55	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	55	suppressed
Anastrozole	Anastrozole	54	suppressed
Pravastatin Sodium	Pravastatin Sodium	54	suppressed
Ramipril	Ramipril	54	suppressed
Gemtesa	Vibegron	53	suppressed
Ropinirole Er	Ropinirole Hcl	53	suppressed
Calcitriol	Calcitriol	50	suppressed
Carbamazepine Er	Carbamazepine	50	suppressed
Risperidone	Risperidone	50	suppressed
Simvastatin	Simvastatin	49	suppressed
Carbamazepine	Carbamazepine	46	suppressed
Solifenacin Succinate	Solifenacin Succinate	46	suppressed
Valacyclovir	Valacyclovir Hcl	44	suppressed
Alendronate Sodium	Alendronate Sodium	43	suppressed
Celecoxib	Celecoxib	43	suppressed
Linzess	Linaclotide	43	suppressed
Mirabegron Er	Mirabegron	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	23
Atenolol	Atenolol	37	suppressed
Lorazepam	Lorazepam	37	14
Loperamide	Loperamide Hcl	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	18
Zonisamide	Zonisamide	36	suppressed
Entresto	Sacubitril/Valsartan	35	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	20
Lactulose	Lactulose	34	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Insulin Lispro	Insulin Lispro	32	11
Rivastigmine	Rivastigmine Tartrate	31	suppressed
Latanoprost	Latanoprost	30	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	27	suppressed
Alogliptin	Alogliptin Benzoate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Fluphenazine Hcl	Fluphenazine Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	13
Diazepam	Diazepam	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	20	suppressed
Colchicine	Colchicine	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Oxcarbazepine	Oxcarbazepine	20	suppressed
Xifaxan	Rifaximin	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Risedronate Sodium	Risedronate Sodium	19	suppressed
Bydureon Bcise	Exenatide Microspheres	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Prednisone	Prednisone	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Clonidine	Clonidine	16	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Primidone	Primidone	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Glipizide	Glipizide	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Temazepam	Temazepam	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Nystatin	Nystatin	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Insulin Glargine Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Briviact	Brivaracetam	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Letrozole	Letrozole	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error